CARYN OLSHANSKY: Open Payments
NPI 1033644992 · NILES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,180 in 146 payments from 20 companies in 2025. Trend: 2023 $5,091 · 2024 $3,668 · 2025 $3,180
Food & beverage: $3,015Education: $166
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $647 |
| Janssen Biotech, Inc. | 17 | $546 |
| Galderma Laboratories, L.P. | 29 | $437 |
| Regeneron Healthcare Solutions, Inc. | 16 | $417 |
| Incyte Corporation | 8 | $215 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $188 |
| Novartis Pharmaceuticals Corporation | 5 | $149 |
| PFIZER INC. | 5 | $124 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $94 |
| GENZYME CORPORATION | 2 | $53 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, NEMLUVIO, RINVOQ, OPZELURA, CIBINQO, LIBTAYO.
Industry payments across IL — which companies pay providers there.
